Praxis director receives RSU and option grants

Praxis Precision Medicines director Jeffrey B. Kindler reported equity awards consisting of restricted stock units and stock options.

Rhea-AI Filing Summary

Praxis Precision Medicines director Jeffrey B. Kindler reported equity awards consisting of restricted stock units and stock options. He was granted 1,371 restricted stock units, each representing a right to receive one share of common stock, bringing his reported common stock holdings to 2,537 shares after the award.

These restricted stock units vest in a single installment on the earlier of June 10, 2027 or the company’s 2027 annual stockholder meeting and will be settled in shares. Kindler was also granted options for 648 shares of common stock at an exercise price of $240.66 per share, vesting in twelve equal monthly installments starting July 10, 2026 through the earlier of June 10, 2027 or the 2027 annual meeting. The filing reflects routine director compensation grants rather than open‑market buying or selling.

Insights

Equity compensation analyst

Routine director equity grants with time-based vesting and no open-market trades.

The filing shows Jeffrey B. Kindler, a director of Praxis Precision Medicines, receiving equity as part of compensation, not trading in the open market. He was granted 1,371 restricted stock units that settle only in common shares once vested.

He also received stock options for 648 shares at an exercise price of $240.66 per share, vesting monthly from July 10, 2026 through the earlier of June 10, 2027 or the 2027 annual meeting. With 2,537 common shares reported following the RSU grant and 648 options outstanding, the scale appears modest for a director position.

Because these are standard time-based awards with no immediate cash transactions or sales, they are best viewed as routine governance and incentive alignment, rather than a directional signal about the company’s near-term prospects.

Insider Trade Summary

Grant/Award: 2,019 shares

Grant/Award 2 txns

Insider KINDLER JEFFREY B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	648	$0.00	$0.00
Grant/Award	Common Stock	1,371	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 648 contracts (Direct); Common Stock — 2,537 shares (Direct)

Footnotes (2)

1. F1. Mr. Kindler was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
2. F2. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

Key Figures

RSU grant size: 1,371 units Shares after RSU grant: 2,537 shares Option grant size: 648 options +3 more

6 metrics

RSU grant size 1,371 units Restricted stock units granted to director on June 10, 2026

Shares after RSU grant 2,537 shares Common stock holdings reported following RSU award

Option grant size 648 options Stock options granted for Praxis common stock

Option exercise price $240.66 per share Conversion or exercise price for stock options

Option expiration June 10, 2036 Expiration date of stock options

RSU vesting date Earlier of June 10, 2027 or 2027 meeting Single-vest RSU schedule tied to 2027 annual meeting

Key Terms

restricted stock units, Stock Option (Right to Buy, exercise price, vesting, +1 more

5 terms

restricted stock units financial

"Mr. Kindler was awarded 1,371 restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Option (Right to Buy financial

"Stock Option (Right to Buy) with 648.0000 shares at $240.6600."

exercise price financial

"conversion_or_exercise_price": "240.6600""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"shall vest in twelve (12) equal monthly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

annual meeting of stockholders financial

"earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Praxis (PRAX) director Jeffrey Kindler report on this Form 4?

Jeffrey Kindler reported two equity awards: 1,371 restricted stock units and stock options for 648 shares of Praxis common stock. The RSUs convert into shares after vesting, while the options allow future purchase of shares at a fixed exercise price.

How and when do Jeffrey Kindler’s 1,371 Praxis (PRAX) RSUs vest?

The 1,371 restricted stock units vest in a single installment on the earlier of June 10, 2027 or the date of Praxis’s 2027 annual stockholder meeting. After vesting, they are settled only by delivering an equal number of Praxis common shares.

What are the key terms of Jeffrey Kindler’s Praxis (PRAX) stock option grant?

The stock option covers 648 Praxis common shares with a $240.66 exercise price. It vests in twelve equal monthly installments beginning July 10, 2026, ending on the earlier of June 10, 2027 or the date of Praxis’s 2027 annual stockholder meeting.

Did Jeffrey Kindler buy or sell Praxis (PRAX) shares in the open market?

No open-market purchases or sales are reported. The Form 4 reflects equity compensation grants—restricted stock units and stock options—coded as acquisitions, rather than discretionary buying or selling of Praxis common shares in the market.

How many Praxis (PRAX) common shares does Jeffrey Kindler hold after these awards?

Following the restricted stock unit award, the Form 4 shows Jeffrey Kindler with 2,537 Praxis common shares reported in the non-derivative holdings column. This figure excludes the 648 shares underlying his newly granted stock options, which are listed separately as derivatives.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 05:23 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KINDLER JEFFREY B

(Last) (First) (Middle)

C/O PRAXIS PRECISION MEDICINES, INC.

99 HIGH STREET, 30TH FLOOR

(Street)

BOSTON MASSACHUSETTS 02110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Praxis Precision Medicines, Inc. [ PRAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A(1)		1,371	A	$0	2,537	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$240.66	06/10/2026		A		648		(2)	06/10/2036	Common Stock	648	$0	648	D

Explanation of Responses:

1. Mr. Kindler was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

2. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

Remarks:

	/s/ Alex Nemiroff, as Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)